FY17 bulk funding for: drug: somavert 15MG (pegvisomant protein 10MG/VIL INJ)

Ended Awarded Last action

Contract number
VA26017J1601
Awardee
Awarding agency
Obligated
$101,183

Award facts

Contract value 100% obligated
$101,183.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Portland, OR 97239, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00002 -$11,312
Supplemental Agreement for work within scope P00001 $30,032
Original award $82,464

About this award

This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 20 of the U.S. Department of Veterans Affairs to Pfizer Inc. The contract is for the supply of the drug Somavert 15mg (pegvisomant protein 10mg/vial injection) with a ceiling value of $101,183.40. The contract has no set-aside designation. This BPA call is placed against Pfizer's existing Federal Supply Schedule (FSS) contract with the VA, which allows Pfizer to provide a wide range of pharmaceutical products and services to support government healthcare initiatives. Pfizer is one of the world's largest pharmaceutical companies and has secured numerous prime contracts and Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $7.31 billion FSS contract with the VA and a $121.9 million contract with the Centers for Disease Control and Prevention for adult vaccines.

Quick answers

Who was awarded contract VA26017J1601?

VA26017J1601 was awarded to Pfizer Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2016.

How much is contract VA26017J1601 worth?

The government has obligated $101,183 on VA26017J1601.

Is contract VA26017J1601 an order under another contract?

Yes. VA26017J1601 is a BPA call under V797D40269-VA797P15A0001, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract VA26017J1601 competed?

The extent of competition for VA26017J1601 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award